Mental health is increasingly being recognized as a key component of elite athletes’ overall functioning and sport performance. Globally, research on antecedents (e.g., sport culture) and consequences (e.g., athletic performance) of mental health and illness in elite athlete populations is growing. However, little is known about the relationship between mental health, mental illness, sport culture, and athletic performance in the Canadian high-performance sport context.
The recent legalization of cannabis in Canada offers a unique opportunity to conduct fundamental research without the bureaucracy issues faced in other countries. The current state of cannabinoid-based therapies have focused their use in the treatment of cancer, pain, inflammation and opioid addiction, and suffer from unwanted side effects and lack of efficacy. Furthermore, the current opioid epidemic and the lack of better pain management strategies highlight the urgency for long-term solutions for chronic pain management.
Women are disproportionately affected by neuro-degenerative disorders compared to men. For years, research has attempted to identify why this phenomenon occurs. The answer may be found in the gut. The intestinal tract contains millions of bacteria that are colonized from birth; These bacteria are essential for keeping the brain and immune system healthy. Changes in the proportions of bacterial species during critical periods of development can have lasting impacts on neuro-inflammation and degradation.
Canadian math scores are in decline. Numerous studies have demonstrated the importance of numerical proficiency for outcomes such as health, employability and financial stability. Therefore, the effectiveness of a child’s math education is key to future success. It is of utmost importance, then, to identify effective math education programs. The proposed project will evaluate JUMP Math – a not-for-profit math curriculum – in a selection of schools within the Thames Valley District School Board (TVDSB).
Our research goal is to improve community-based services for persons with developmental disabilities. We'll test a service that helps people who are in crisis because their caregivers find it hard to meet their needs. We'll develop and test a program to teach therapists how to involve parents in treatment decisions. Finally, we'll test a program to teach kids to cross the street safely. Our partner, St.Amant, serves thousands of individuals and families every year. St.Amant and other agencies can use what we learn to help those people live safe and independent lives in their communities.
While companies are looking to hire the most qualified candidate to fill their positions, they often have a difficult time identifying the right candidate for the job using traditional hiring practices. However, one major barrier is that companies may over-rely on traditional hiring methods such as interviews that may not be the best way to select the most qualified candidates. This is because employers may overly-rely on their experience and intuition, even though they are often led astray.
As the digital landscape continues to evolve, it becomes increasingly more important to understand how technology affects cognition, emotion, and behaviour. This rapid growth of technology has also led to the development of empathetic computing programs with the goal of augmenting people’s lives. It is crucial to discover the practical implications of these systems. This project will focus on analyzing Maslo’s (and the industry’s) empathetic computing technologies through the lenses of cognitive psychology, neuroscience, and evolutionary psychology.
As part of this proposal the intern will be working with DME to develop and examine the viability of data-driven point-of-care system for the assessment of suicide risk. DME is a Canadian start-up company in the business of developing cloud-based point-of-care monitoring systems for the management of psychiatric illnesses. DME has developed algorithms to diagnose and predict optimal treatment for major depression disorder and schizophrenia, and has been allowed patents describing its technology in Canada, the USA, and Australia. If found acceptable the algorithms
In this project, Axem Neurotechnology will test a prototype of its first product—a brain measurement device to be used in rehabilitation following stroke. The prototype will be compared to an established device (currently used exclusively in research) using measurements on healthy people, and will also be used to take measurements on stroke patients in both a hospital and home setting. These activities will provide value to the company as they will result in validation of their technology, as well as publicity through publication in scientific journals.